BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: López-Serrano P, Briongos ELF, Alonso EC, Pérez-Calle JL, Rodríguez CF. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy. World J Hepatol 2015; 7(3): 539-547 [PMID: 25848477 DOI: 10.4254/wjh.v7.i3.539]
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/539.htm
Number Citing Articles
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host2016; : 69 doi: 10.1128/9781555819040.ch3
Özgür Dağlı, Meliha Kasapoğlu aksoy. Hepatitis B and hepatitis C infection prevalence in ankylosing spondylitis patientsOrtadoğu Tıp Dergisi 2018; 10(3): 297 doi: 10.21601/ortadogutipdergisi.390938
Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W. G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe. Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia BBlood Advances 2019; 3(21): 3241 doi: 10.1182/bloodadvances.2019000811
David Alexanian, Aleksandr Birg, Nicholas Volpicelli, Joseph Glass, Denis McCarthy. Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?Digestive Diseases and Sciences 2018; 63(5): 1143 doi: 10.1007/s10620-018-5028-1
Rebecca L. Yanovsky, Michael McLeod, A. Razzaque Ahmed. Treatment of pemphigus vulgaris: part 1 – current therapiesExpert Review of Clinical Immunology 2019; 15(10): 1047 doi: 10.1080/1744666X.2020.1672535
Sydney Chi‐Wai Tang, Andrew Kui‐Man Wong, Siu‐Ka Mak. Clinical practice guidelines for the provision of renal service in Hong Kong: General NephrologyNephrology 2019; 24(S1): 9 doi: 10.1111/nep.13500
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and DMicrobiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
Claudio Bonifati, Viviana Lora, Dario Graceffa, Lorenzo Nosotti. Management of psoriasis patients with hepatitis B or hepatitis C virus infectionWorld Journal of Gastroenterology 2016; 22(28): 6444-6455 doi: 10.3748/wjg.v22.i28.6444
Jing Fang, Wenge Li, Min Tan, Wen Chen, Cong Zhang, Wenbo Wang, Qianqian Xu, Xinzhen Guo. Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observationInternational Urology and Nephrology 2018; 50(9): 1653 doi: 10.1007/s11255-018-1867-0
Rossella Talotta, Fabiola Atzeni, Piercarlo Sarzi Puttini. Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case reportBMC Pharmacology and Toxicology 2016; 17(1) doi: 10.1186/s40360-016-0060-2
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José M. Peña, José V. Fernández-Montero, Laura Benítez, Isabella Esposito, Pablo Barreiro. Emerging Challenges in Managing Hepatitis B in HIV PatientsCurrent HIV/AIDS Reports 2015; 12(3): 344 doi: 10.1007/s11904-015-0275-7
Francesco Saccà, Chiara Pane, Anna De Rosa, Margherita Matarazzo, Vincenzo Brescia Morra. Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infectionNeurological Sciences 2017; 38(3): 501 doi: 10.1007/s10072-016-2726-3